Literature DB >> 18544683

Polyphosphate enhances fibrin clot structure.

Stephanie A Smith1, James H Morrissey.   

Abstract

Polyphosphate, a linear polymer of inorganic phosphate, is present in platelet dense granules and is secreted on platelet activation. We recently reported that polyphosphate is a potent hemostatic regulator, serving to activate the contact pathway of blood clotting and accelerate factor V activation. Because polyphosphate did not alter thrombin clotting times, it appeared to exert all its procoagulant actions upstream of thrombin. We now report that polyphosphate enhances fibrin clot structure in a calcium-dependent manner. Fibrin clots formed in the presence of polyphosphate had up to 3-fold higher turbidity, had higher mass-length ratios, and exhibited thicker fibers in scanning electron micrographs. The ability of polyphosphate to enhance fibrin clot turbidity was independent of factor XIIIa activity. When plasmin or a combination of plasminogen and tissue plasminogen activators were included in clotting reactions, fibrin clots formed in the presence of polyphosphate exhibited prolonged clot lysis times. Release of polyphosphate from activated platelets or infectious microorganisms may play an important role in modulating fibrin clot structure and increasing its resistance to fibrinolysis. Polyphosphate may also be useful in enhancing the structure of surgical fibrin sealants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544683      PMCID: PMC2556616          DOI: 10.1182/blood-2008-03-145755

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.

Authors:  J P Collet; C Nagaswami; D H Farrell; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-01       Impact factor: 8.311

2.  Analyzing fibrin clot structure using a microplate reader.

Authors:  A S Wolberg; D A Gabriel; M Hoffman
Journal:  Blood Coagul Fibrinolysis       Date:  2002-09       Impact factor: 1.276

3.  Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site.

Authors:  Sergiy Yakovlev; Sergey Gorlatov; Kenneth Ingham; Leonid Medved
Journal:  Biochemistry       Date:  2003-07-01       Impact factor: 3.162

4.  Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.

Authors:  Amy V Cooper; Kristina F Standeven; Robert A S Ariëns
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

5.  Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.

Authors:  A Collen; S M Smorenburg; E Peters; F Lupu; P Koolwijk; C Van Noorden; V W van Hinsbergh
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

6.  Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells.

Authors:  Lihong Wang; Cresson D Fraley; Jesika Faridi; Arthur Kornberg; Richard A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-11       Impact factor: 11.205

7.  Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.

Authors:  Aldo Profumo; Marco Turci; Gianluca Damonte; Fabio Ferri; Davide Magatti; Barbara Cardinali; Carla Cuniberti; Mattia Rocco
Journal:  Biochemistry       Date:  2003-10-28       Impact factor: 3.162

8.  Induction of calcification in MC3T3-E1 cells by inorganic polyphosphate.

Authors:  Y Kawazoe; T Shiba; R Nakamura; A Mizuno; K Tsutsumi; T Uematsu; M Yamaoka; M Shindoh; T Kohgo
Journal:  J Dent Res       Date:  2004-08       Impact factor: 6.116

9.  Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.

Authors:  D L Sauls; A S Wolberg; M Hoffman
Journal:  J Thromb Haemost       Date:  2003-02       Impact factor: 5.824

10.  Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk.

Authors:  Alisa S Wolberg; Dougald M Monroe; Harold R Roberts; Maureane Hoffman
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

View more
  66 in total

Review 1.  Hageman factor, platelets and polyphosphates: early history and recent connection.

Authors:  J Caen; Q Wu
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

2.  Myeloma cells contain high levels of inorganic polyphosphate which is associated with nucleolar transcription.

Authors:  Maria D Jimenez-Nuñez; David Moreno-Sanchez; Laura Hernandez-Ruiz; Alicia Benítez-Rondán; Ana Ramos-Amaya; Beatriz Rodríguez-Bayona; Francisco Medina; José Antonio Brieva; Felix A Ruiz
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

Review 3.  Clot Structure and Implications for Bleeding and Thrombosis.

Authors:  Emily Mihalko; Ashley C Brown
Journal:  Semin Thromb Hemost       Date:  2019-10-15       Impact factor: 4.180

4.  2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-23       Impact factor: 8.311

Review 5.  From underlying chemistry to therapeutic potential: open questions in the new field of lysine polyphosphorylation.

Authors:  Amanda Bentley-DeSousa; Michael Downey
Journal:  Curr Genet       Date:  2018-06-07       Impact factor: 3.886

6.  Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Georgi Georgiev; Anja Klemmer; Chelsea Brain; Paul Y Kim; Nicola J Mutch
Journal:  Blood       Date:  2016-09-30       Impact factor: 22.113

7.  Novel family of insect salivary inhibitors blocks contact pathway activation by binding to polyphosphate, heparin, and dextran sulfate.

Authors:  Patricia H Alvarenga; Xueqing Xu; Fabiano Oliveira; Andrezza C Chagas; Clarissa R Nascimento; Ivo M B Francischetti; Maria A Juliano; Luiz Juliano; Julio Scharfstein; Jesus G Valenzuela; José M C Ribeiro; John F Andersen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-03       Impact factor: 8.311

8.  Polyphosphate as a general procoagulant agent.

Authors:  S A Smith; J H Morrissey
Journal:  J Thromb Haemost       Date:  2008-07-28       Impact factor: 5.824

Review 9.  New players in haemostasis and thrombosis.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Thromb Haemost       Date:  2014-02-27       Impact factor: 5.249

Review 10.  Polyphosphate and omptins: novel bacterial procoagulant agents.

Authors:  Thomas H Yun; James H Morrissey
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.